Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company’s lead drug candidate is for the management of fibromyalgia pain.
Tonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares Tumble
Where Today's News Shapes Tomorrow
